These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7324949)

  • 1. Evaluation of a new sustained-release theophylline tablet for children.
    Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
    Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur.
    Karlsson S; Lührmann B; Bahner ML; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):342-6. PubMed ID: 3623739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of food on the absorption rate and bioavailability of a sustained release theophylline preparation.
    Pedersen S; Moeller-Petersen J
    Allergy; 1982 Oct; 37(7):531-4. PubMed ID: 7181050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum theophylline levels in young children receiving a sustained-release theophylline tablet.
    Howard ML; Baldwin JN; Kobayashi RH; Jensen BK
    J Asthma; 1984; 21(5):299-303. PubMed ID: 6501169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
    Kelly HW; Murphy S
    Am J Hosp Pharm; 1979 Dec; 36(12):1698-701. PubMed ID: 525646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum profile and bioavailability of a controlled-release theophylline formulation for once-daily use: comparison with a 12-hr preparation.
    Cohen BM
    J Asthma; 1984; 21(5):305-9. PubMed ID: 6389484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
    Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
    S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma.
    Pedersen S; Steffensen G
    J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new sustained-release theophylline suspension for asthmatic children: evaluation of serum theophylline concentrations.
    Boner AL; Vallone G; Valletta E; Bernocchi D; Plebani M
    Int J Clin Pharmacol Res; 1987; 7(5):345-50. PubMed ID: 3667007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma.
    Weinberger M; Hendeles L; Wong L
    J Pediatr; 1981 Jul; 99(1):145-52. PubMed ID: 7252652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)].
    Kishida M; Okuma M; Uekusa T; Akimoto K; Obata T; Akazawa A; Odajima Y; Nagakura T; Iikura Y; Hukushima K
    Arerugi; 1988 Apr; 37(4):218-25. PubMed ID: 3228360
    [No Abstract]   [Full Text] [Related]  

  • 17. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
    Leeds NH; Gal P; Purohit AA; Walter JB
    J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline concentrations in serum and saliva after oral microcrystalline and sustained-release preparations in asthmatics.
    Munch EP; Søndergaard I; Weeke B
    Allergy; 1981 Feb; 36(2):89-98. PubMed ID: 7235205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.